ArticleInternational urogynecology journal2026
Association of Preoperative Inflammatory and Immune Markers with Mesh Exposure After Transvaginal Mesh Surgery for Pelvic Organ Prolapse.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introduction and hypothesisThis study was conducted to investigate the associations between baseline absolute monocyte count (AMC), absolute lymphocyte count (ALC), the platelet-to-lymphocyte ratio (PLR), and the risk of mesh exposure following transvaginal mesh (TVM) surgery for pelvic organ prolapse (POP).
methodsThis prospective cohort study included 206 symptomatic POP patients who underwent TVM treatment with titanium-coated polypropylene mesh (Tiloop) from June 2015 to December 2021 at Peking Union Medical College Hospital. Patients were classified into mesh exposure (n = 23) and non-exposure (n = 183) groups. Baseline hematological indicators, including AMC, ALC, PLR, the neutrophil-to-lymphocyte ratio, the lymphocyte-to-monocyte ratio, and the prognostic nutritional index, were recorded. Restricted cubic spline (RCS) analysis and Cox proportional hazards models were used to assess the associations between these indicators and mesh-exposure risk.
resultsMesh exposure occurred in 11.2% of the patients. Significant differences in AMC, ALC, and PLR were detected between the exposure and non-exposure groups. RCS analysis revealed inverse linear associations between AMC and ALC and mesh exposure risk and a positive linear association for the PLR. Lower AMC (adjusted hazard ratio [aHR] = 0.424; 95% CI 0.228-0.786) and ALC (aHR = 0.422; 95% CI 0.255-0.698) were associated with increased mesh exposure risk, whereas higher PLR (aHR = 2.170; 95% CI 1.486-3.169) was associated with increased risk.
conclusionLow AMC and ALC and elevated PLR were independently associated with an increased risk of mesh exposure after TVM surgery.
Indexed as
Identifiers
41240110What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.